Applied Therapeutics, Inc. — Director's Dealing 2019

May 20, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-16

Reporting Person: Funtleyder Leslie D. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-16	Common Stock	C	3314	—	Acquired	12485	Direct
2019-05-16	Common Stock	C	1325	—	Acquired	13810	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-16	Series A Preferred Stock	$	C	3314	Disposed		Common Stock (3314)	Direct
2019-05-16	Series B Preferred Stock	$	C	1325	Disposed		Common Stock (1325)	Direct

Footnotes

F1: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019.